Winton Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72M Buy
60,348
+52,848
+705% +$3.6M 0.15% 173
2026
Q1
$485K Buy
+7,500
New +$529K 0.02% 721
2025
Q4
Sell
-3,500
Closed -$257K 1001
2025
Q3
$257K Buy
+3,500
New +$232K 0.01% 648
2024
Q2
Sell
-148,130
Closed -$6.03M 640
2024
Q1
$6.03M Buy
+148,130
New +$5.55M 0.43% 39
2023
Q2
Sell
-17,040
Closed -$651K 911
2023
Q1
$651K Buy
+17,040
New +$799K 0.04% 595
2022
Q2
Sell
-124,869
Closed -$4.98M 995
2022
Q1
$4.98M Sell
124,869
-76,417
-38% -$2.72M 0.26% 67
2021
Q4
$8.09M Buy
201,286
+159,304
+379% +$5.95M 0.49% 25
2021
Q3
$1.71M Sell
41,982
-7,042
-14% -$294K 0.1% 254
2021
Q2
$2.23M Buy
49,024
+2,889
+6% +$128K 0.12% 148
2021
Q1
$1.92M Sell
46,135
-3,201
-6% -$146K 0.11% 165
2020
Q4
$2.11M Sell
49,336
-152,765
-76% -$5.49M 0.15% 90
2020
Q3
$5.31M Buy
202,101
+106,406
+111% +$2.96M 0.17% 106
2020
Q2
$2.57M Buy
95,695
+10,812
+13% +$244K 0.07% 524
2020
Q1
$1.53M Sell
84,883
-15,291
-15% -$290K 0.04% 650
2019
Q4
$1.78M Buy
100,174
+79,775
+391% +$1.38M 0.02% 841
2019
Q3
$316K Buy
+20,399
New +$336K ﹤0.01% 1261

Other funds holding HALO

Winton Group's HALO Position: Q2 2026 in Review

Winton Group increased its Halozyme (HALO) stake by 705% in Q2 2026, buying an estimated $3.6M and bringing the position to 60,348 shares worth $4.72M. The position accounts for 0.15% of the portfolio, ranked #173.

Winton Group first reported a position in HALO in Q3 2019 and has held it in 16 quarters since. The position peaked at $8.09M in Q4 2021. 405 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Winton Group held 60,348 shares of Halozyme worth $4.72M as of Q2 2026.
  • Winton Group bought 52,848 Halozyme shares in Q2 2026, an estimated $3.6M.
  • Halozyme made up 0.15% of Winton Group's portfolio in Q2 2026, its #173 holding.
  • Winton Group first reported a position in Halozyme in Q3 2019 and has held it in 16 quarters since.
  • Winton Group's Halozyme position peaked at $8.09M in Q4 2021.
  • 405 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.